The specific purpose of the corporation shall include, without limitation: to evolve and provide research, training, and education in the development of Ketamine's use for psychiatric and psychotheraputic science and clinical practice.
Largest programs · fiscal year 2024
Ketamine is the only legally available medicine with psychedelic therapeutic methodologies and practices that will serve as a model and development ground as other psychoactive medicines become available for clinical practice. This makes for streamlined and creative research, with appropriate safeguards with FDA and IRB approvals as appropriate.KRF's 2024 achievements were as follows: Completed Ph… Read more
Ketamine is the only legally available medicine with psychedelic therapeutic methodologies and practices that will serve as a model and development ground as other psychoactive medicines become available for clinical practice. This makes for streamlined and creative research, with appropriate safeguards with FDA and IRB approvals as appropriate.KRF's 2024 achievements were as follows: Completed Phantom Limb Protocol and submitted it to FDAin Review. IRB gave conditional approval based on FDA review Our Acute Trauma PTSD protocol was sent, taught and utilized in the Ukraine, Israel, North Carolina's disaster and elsewhere. KRF took leadership in dealing with trauma treatment worldwide and presented its protocol and is providing ongoing training KRF's protocol for Women's Wellbeing with the treatment of luteal face PMS and PMDD was submitted to FDA for an INDin review Setting Standards for Safe and Effective Ketamine Use-- KRF as the standard bearer for the use of ketamine clinically: And for its safe use personally. KRF published major articles on KAP in academic journals, participated in numerous podcasts and programs, and had several journalistic pieces published.
$252,349 spent · 41.9% of program spending
KRF's Ketamine Training Center continued its practitioner training programs with over 1000 persons trained as of 2024. Our 2nd Annual Dharma K program was held as well as our Advanced Sharing program. WE remain as the principle and most complete training organization for KAP and Ketamine work. The BIPOC program continues to support diversity with scholarship assistance to trainees.KRF's Ketamine P… Read more
KRF's Ketamine Training Center continued its practitioner training programs with over 1000 persons trained as of 2024. Our 2nd Annual Dharma K program was held as well as our Advanced Sharing program. WE remain as the principle and most complete training organization for KAP and Ketamine work. The BIPOC program continues to support diversity with scholarship assistance to trainees.KRF's Ketamine Psychotherapy Associates membership program now has over 100 members and provides ongoing support for practitioners and KAP practices. Our Access to Care program provide funds for our members to support those who cannot afford care.
$349,701 spent · 58.1% of program spending
Where each dollar went · fiscal year 2024
Of every dollar it spent, 94¢ went to programs, 4¢ to management and 2¢ to fundraising.
Programs $602,050
Management $23,603
Fundraising $15,750
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
94%
Meets
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$674,218Fiscal year 2024
Expenses$641,403Fiscal year 2024
Total assets$560,755Fiscal year 2024
Total liabilities$1,964Fiscal year 2024
Fiscal year ending December2024
Revenue$674,218
Expenses$641,403
Net income$32,815
Net assets$558,791
Notable sources of revenue
Percent of total revenue
Contributions
$323,885
48.0%
Program services
$349,322
51.8%
Investment income
$227
0.0%
Other (net)
$784
0.1%
Assets / debt
Total assets
$560,755
Total liabilities
$1,964
Net assets
$558,791
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$884,311
Expenses$958,705
Net income−$74,394
Net assets$525,977
Notable sources of revenue
Percent of total revenue
Contributions
$198,695
22.5%
Program services
$691,065
78.1%
Investment income
$536
0.1%
Other (net)
−$5,985
−0.7%
Assets / debt
Total assets
$527,941
Total liabilities
$1,964
Net assets
$525,977
Compensation
Officers and key employees
$172,737
Share of expenses
18.0%
Fiscal year ending December2022
Revenue$888,575
Expenses$940,075
Net income−$51,500
Net assets$600,371
Notable sources of revenue
Percent of total revenue
Contributions
$262,761
29.6%
Program services
$625,612
70.4%
Investment income
$202
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$609,263
Total liabilities
$8,892
Net assets
$600,371
Compensation
Officers and key employees
$135,166
Share of expenses
14.4%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?